Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
Brain circuitry outside the synaptic cleft.
The effect of intravenous immunoglobulin on neuromyelitis optica.
Severe dystonia as the first manifestation of neuromyelitis optica.
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.
Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Pediatric Multiple Sclerosis.
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.
Epstein-Barr virus cause of multiple sclerosis.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
Xavier Montalban: a pioneer in understanding multiple sclerosis.
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
B cell exchange across the blood-brain barrier in multiple sclerosis.

Pages